Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 413 of 684

Advanced search

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07701369: Relevance of Artificial Intelligence-Assisted Echocardiography for Left Ventricular Ejection Fraction Assessment in Geriatric Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07692685: Pharmacokinetic Effect of Y-3 for Injection on Rosuvastatin Calcium Tablets in Healthy Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07633288: A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07630961: Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07596173: A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07507513: The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07492498: Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07415057: Simulation on the Enhancement of Clinical Communication Competencies in Nursing Students

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07360067: Prospective Cohort Study of Bachmann Bundle Versus Right Atrial Appendage Pacing: Impact on Atrial Cardiomyopathy Evaluated by Echocardiographic Parameters and Clinical Outcome

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07272499: Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07270380: Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07192432: Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT07170527: Long-Term Outcomes and Post-Intensive Care Syndrome: Investigating the Associations Between Metabolic Signatures and Physical Functioning in Critically Ill Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT06937931: A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT06825559: Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT06510166: The Effect of Distraction Methods Used During Inhalation Therapy on Children's Fear and Anxiety: : Randomize Controlled Study

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT06484088: Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT06422338: A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT06325696: H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT06199232: Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT05911269: Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT05764746: Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT05282901: Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT05141682: Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT02877394: Use of a Squatting Assist Device in Patients With Constipation

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT02772003: DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT02506933: Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT02450851: Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT02257892: Novel Genetic Disorders of the Immune System

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT02211768: Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT01934660: Links Between Inflammation and Cardiometabolic Diseases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT01621581: AAV2-GDNF for Advanced Parkinson s Disease

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT01306019: Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT01109394: Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT00756769: Systemic Lupus Erythematosus in Gullah Health

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT00340405: Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT00250159: Natural History Study of Patients With Excess Androgen

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT00006150: Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 28Researchclinicaltrials.govTier 1 · Trial registry

NCT00001456: Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Panel Recommends Compounding Unapproved Peptides

조선일보Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Aribio Completes Global Phase 3 Trial of AR1001... Topline Results to Be Announced in November

아시아경제Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

South Korea joins WHO’s transitional list of top medical device regulators - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Cooley Owes $25.4M Judgment To NJ Biotech Co. Founder

Law360Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

These 6 Popular Peptides May Soon Be Easier to Get — Here’s What That Means

Everyday HealthOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

CG Oncology Announces Lancet Oncology Publication of Phase 3 BOND-003 Cohort C Results for Cretostimogene in High-Risk BCG-Unresponsive Bladder Cancer

Quiver QuantitativeOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

About 81% of BOND-003 patients maintained their bladders at 24 months

Stock TitanOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Argenx enters biotech buyer class with $2.2B Forte takeout

BioCenturyOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Lushang Freda Pharmaceutical Co., Ltd. Class A – SSE:600223

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Yale, Biohaven Win $4M In Biotech Trade Secret Trial

Law360Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Protecting Biotech Innovation In The Platform Knowledge Era

Law360Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Korea’s IMGT launches world-first confirmatory trial for ultrasound drug delivery - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Placebo effect forces Korea biotechs to rethink late-stage trial design - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

These 6 Popular Peptides May Soon Be Easier to Get — Here’s What That Means

YahooOriginal source

🇺🇸Jul 28Researchorbimed.comTier 2 · Direct publisher

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline

OrbiMedOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Oak Hill Bio

Fierce BiotechOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Veraxa Biotech (VRXA) moves bispecific ADC VXA-222 program forward

Stock TitanOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA grants orphan drug status to experimental PAH treatment

Pulmonary Hypertension NewsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

NewMediaWireOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform

Yahoo! Finance CanadaOriginal source

🇺🇸Jul 28Researchrarediseases.orgTier 2 · Direct publisher

Laws Shaping Rare Disease Care: TEFRA – Tax Equity and Fiscal Responsibility Act of 1982

NORD Rare DiseasesOriginal source